Edgestream Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $513K | Buy |
1,024
+379
| +59% | +$182K | 0.02% | 792 |
|
|
2026
Q1 | $317K | Sell |
645
-1,763
| -73% | -$957K | 0.01% | 792 |
|
|
2025
Q4 | $1.4M | Buy |
+2,408
| New | +$1.36M | 0.04% | 615 |
|
|
2025
Q3 | – | Sell |
-8,269
| Closed | -$3.35M | – | 1058 |
|
|
2025
Q2 | $3.35M | Sell |
8,269
-677
| -8% | -$283K | 0.09% | 402 |
|
|
2025
Q1 | $4.45M | Sell |
8,946
-1,240
| -12% | -$672K | 0.15% | 256 |
|
|
2024
Q4 | $5.3M | Buy |
10,186
+5,542
| +119% | +$3.05M | 0.23% | 134 |
|
|
2024
Q3 | $2.87M | Sell |
4,644
-1,892
| -29% | -$1.12M | 0.13% | 293 |
|
|
2024
Q2 | $3.61M | Buy |
6,536
+3,678
| +129% | +$2.11M | 0.17% | 200 |
|
|
2024
Q1 | $1.66M | Buy |
+2,858
| New | +$1.6M | 0.08% | 381 |
|
|
2023
Q4 | – | Sell |
-2,491
| Closed | -$1.26M | – | 1063 |
|
|
2023
Q3 | $1.26M | Buy |
+2,491
| New | +$1.33M | 0.1% | 326 |
|
|
2022
Q4 | – | Sell |
-1,300
| Closed | -$659K | – | 639 |
|
|
2022
Q3 | $659K | Buy |
1,300
+426
| +49% | +$238K | 0.05% | 325 |
|
|
2022
Q2 | $475K | Buy |
874
+10
| +1% | +$5.5K | 0.04% | 413 |
|
|
2022
Q1 | $510K | Sell |
864
-290
| -25% | -$167K | 0.04% | 419 |
|
|
2021
Q4 | $770K | Sell |
1,154
-8,361
| -88% | -$5.22M | 0.05% | 348 |
|
|
2021
Q3 | $5.44M | Buy |
9,515
+4,690
| +97% | +$2.57M | 0.34% | 92 |
|
|
2021
Q2 | $2.43M | Sell |
4,825
-21,064
| -81% | -$9.94M | 0.14% | 202 |
|
|
2021
Q1 | $11.8M | Buy |
25,889
+4,980
| +24% | +$2.38M | 0.66% | 29 |
|
|
2020
Q4 | $9.74M | Buy |
+20,909
| New | +$9.8M | 0.49% | 63 |
|
|
2020
Q3 | – | Sell |
-16,026
| Closed | -$5.81M | – | 357 |
|
|
2020
Q2 | $5.81M | Buy |
16,026
+7,904
| +97% | +$2.65M | 0.31% | 96 |
|
|
2020
Q1 | $2.3M | Buy |
8,122
+6,128
| +307% | +$1.93M | 0.21% | 129 |
|
|
2019
Q4 | $648K | Sell |
1,994
-11,351
| -85% | -$3.44M | 0.03% | 262 |
|
|
2019
Q3 | $3.89M | Buy |
+13,345
| New | +$3.82M | 0.37% | 93 |
|
|
2018
Q3 | – | Sell |
-1,143
| Closed | -$237K | – | 333 |
|
|
2018
Q2 | $237K | Buy |
+1,143
| New | +$243K | 0.05% | 238 |
|
|
2018
Q1 | – | Sell |
-1,253
| Closed | -$238K | – | 264 |
|
|
2017
Q4 | $238K | Buy |
+1,253
| New | +$240K | 0.28% | 77 |
|
|
2017
Q2 | – | Sell |
-2,851
| Closed | -$438K | – | 154 |
|
|
2017
Q1 | $438K | Buy |
2,851
+1,151
| +68% | +$176K | 0.19% | 101 |
|
|
2016
Q4 | $240K | Sell |
1,700
-7,722
| -82% | -$1.14M | 0.5% | 62 |
|
|
2016
Q3 | $1.5M | Buy |
+9,422
| New | +$1.45M | 0.83% | 31 |
|
|
2016
Q2 | – | Sell |
-1,508
| Closed | -$214K | – | 76 |
|
|
2016
Q1 | $214K | Buy |
+1,508
| New | +$202K | 0.24% | 68 |
|
|
2015
Q3 | – | Sell |
-4,274
| Closed | -$555K | – | 105 |
|
|
2015
Q2 | $555K | Sell |
4,274
-1,586
| -27% | -$207K | 0.38% | 64 |
|
|
2015
Q1 | $787K | Buy |
5,860
+2,763
| +89% | +$356K | 1.02% | 29 |
|
|
2014
Q4 | $388K | Sell |
3,097
-11,710
| -79% | -$1.42M | 0.89% | 40 |
|
|
2014
Q3 | $1.8M | Sell |
14,807
-14,761
| -50% | -$1.79M | 1.57% | 18 |
|
|
2014
Q2 | $3.49M | Buy |
+29,568
| New | +$3.48M | 2.22% | 13 |
|
Other funds holding TMO
Edgestream Partners's TMO Position: Q2 2026 in Review
Edgestream Partners increased its Thermo Fisher Scientific (TMO) stake by 59% in Q2 2026, buying an estimated $182K and bringing the position to 1,024 shares worth $513K. The position accounts for 0.02% of the portfolio, ranked #792.
Edgestream Partners first reported a position in TMO in Q2 2014 and has held it in 33 quarters since. The position peaked at $11.8M in Q1 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Edgestream Partners held 1,024 shares of Thermo Fisher Scientific worth $513K as of Q2 2026.
- Edgestream Partners bought 379 Thermo Fisher Scientific shares in Q2 2026, an estimated $182K.
- Thermo Fisher Scientific made up 0.02% of Edgestream Partners's portfolio in Q2 2026, its #792 holding.
- Edgestream Partners first reported a position in Thermo Fisher Scientific in Q2 2014 and has held it in 33 quarters since.
- Edgestream Partners's Thermo Fisher Scientific position peaked at $11.8M in Q1 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.